The Next 500 Years: Engineering Life to Reach New Worlds

An argument that we have a moral duty to explore other planets and solar systems--because human life on Earth has an expiration date.

Inevitably, life on Earth will come to an end, whether by climate disaster, cataclysmic war, or the death of the sun in a few billion years. To avoid extinction, we will have to find a new home planet, perhaps even a new solar system, to inhabit. In this provocative and fascinating book, Christopher Mason argues that we have a moral duty to do just that. As the only species aware that life on Earth has an expiration date, we have a responsibility to act as the shepherd of life-forms--not only for our species but for all species on which we depend and for those still to come (by accidental or designed evolution). Mason argues that the same capacity for ingenuity that has enabled us to build rockets and land on other planets can be applied to redesigning biology so that we can sustainably inhabit those planets. And he lays out a 500-year plan for undertaking the massively ambitious project of reengineering human genetics for life on other worlds.

As they are today, our frail human bodies could never survive travel to another habitable planet. Mason describes the toll that long-term space travel took on astronaut Scott Kelly, who returned from a year on the International Space Station with changes to his blood, bones, and genes. Mason proposes a ten-phase, 500-year program that would engineer the genome so that humans can tolerate the extreme environments of outer space--with the ultimate goal of achieving human settlement of new solar systems. He lays out a roadmap of which solar systems to visit first, and merges biotechnology, philosophy, and genetics to offer an unparalleled vision of the universe to come.

Christopher E. Mason is a geneticist and computational biologist who has been a Principal Investigator and Co-investigator of 11 NASA missions and projects. He is Professor at Weill Cornell Medicine, with affiliate appointments at the Meyer Cancer Center, Memorial Sloan Kettering Cancer Center, the Information Society Project (ISP) at Yale Law School, and the Consortium for Space Genetics at Harvard Medical School.